<DOC DOCNO="nw/wsj/13/wsj_1392@1392@wsj@nw@en@on">
<TEXT PARTNO="000">
<COREF ID="0" TYPE="IDENT">Roche Holding AG , parent of the Swiss chemical and pharmaceutical group ,</COREF> said <COREF ID="0" TYPE="IDENT">its</COREF> group sales rose 22 % in the first nine months of <COREF ID="1" TYPE="IDENT">the year</COREF> to 7.32 billion francs -LRB- $ 4.51 billion -RRB- .
<COREF ID="0" TYPE="IDENT">The company</COREF> reported good gains in all of <COREF ID="0" TYPE="IDENT">its</COREF> divisions .
<COREF ID="0" TYPE="IDENT">Roche</COREF> also said <COREF ID="0" TYPE="IDENT">it</COREF> expects a `` considerable rise '' in <COREF ID="1" TYPE="IDENT">1989</COREF> group profit from the 641.5 million - franc -LRB- $ 396 million -RRB- net in 1988 .
</TEXT>
</DOC>
